Literature DB >> 19084436

Animal models of henipavirus infection: a review.

Hana M Weingartl1, Yohannes Berhane, Markus Czub.   

Abstract

Hendra virus (HeV) and Nipah virus (NiV) form a separate genus Henipavirus within the family Paramyxoviridae, and are classified as biosafety level four pathogens due to their high case fatality rate following human infection and because of the lack of effective vaccines or therapy. Both viruses emerged from their natural reservoir during the last decade of the 20th century, causing severe disease in humans, horses and swine, and infecting a number of other mammalian species. The current review summarises current published data relating to experimental infection of small and large animals, including the natural reservoir species, the Pteropus bat, with HeV or NiV. Susceptibility to infection and virus distribution in the individual species is discussed, along with the pathogenesis, pathological changes, and potential routes of transmission.

Entities:  

Mesh:

Year:  2008        PMID: 19084436     DOI: 10.1016/j.tvjl.2008.10.016

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  30 in total

Review 1.  Hendra and nipah infection: pathology, models and potential therapies.

Authors:  Frederic Vigant; Benhur Lee
Journal:  Infect Disord Drug Targets       Date:  2011-06

Review 2.  A treatment for and vaccine against the deadly Hendra and Nipah viruses.

Authors:  Christopher C Broder; Kai Xu; Dimitar B Nikolov; Zhongyu Zhu; Dimiter S Dimitrov; Deborah Middleton; Jackie Pallister; Thomas W Geisbert; Katharine N Bossart; Lin-Fa Wang
Journal:  Antiviral Res       Date:  2013-07-06       Impact factor: 5.970

Review 3.  Henipavirus outbreaks to antivirals: the current status of potential therapeutics.

Authors:  Christopher C Broder
Journal:  Curr Opin Virol       Date:  2012-03-21       Impact factor: 7.090

Review 4.  Immunization strategies against henipaviruses.

Authors:  Christopher C Broder; Thomas W Geisbert; Kai Xu; Dimitar B Nikolov; Lin-Fa Wang; Deborah Middleton; Jackie Pallister; Katharine N Bossart
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

5.  Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection.

Authors:  Barry Rockx; Douglas Brining; Joshua Kramer; Julie Callison; Hideki Ebihara; Keith Mansfield; Heinz Feldmann
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  Ubiquitin-regulated nuclear-cytoplasmic trafficking of the Nipah virus matrix protein is important for viral budding.

Authors:  Yao E Wang; Arnold Park; Michael Lake; Mickey Pentecost; Betsabe Torres; Tatyana E Yun; Mike C Wolf; Michael R Holbrook; Alexander N Freiberg; Benhur Lee
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

7.  Nipah virus entry and egress from polarized epithelial cells.

Authors:  Boris Lamp; Erik Dietzel; Larissa Kolesnikova; Lucie Sauerhering; Stephanie Erbar; Hana Weingartl; Andrea Maisner
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

8.  Nipah Virus C and W Proteins Contribute to Respiratory Disease in Ferrets.

Authors:  Benjamin A Satterfield; Robert W Cross; Karla A Fenton; Viktoriya Borisevich; Krystle N Agans; Daniel J Deer; Jessica Graber; Christopher F Basler; Thomas W Geisbert; Chad E Mire
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

9.  Henipavirus pathogenesis in human respiratory epithelial cells.

Authors:  Olivier Escaffre; Viktoriya Borisevich; J Russ Carmical; Deborah Prusak; Joseph Prescott; Heinz Feldmann; Barry Rockx
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

10.  Experimental inoculation study indicates swine as a potential host for Hendra virus.

Authors:  Mingyi Li; Carissa Embury-Hyatt; Hana M Weingartl
Journal:  Vet Res       Date:  2010-01-20       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.